Baseline right ventricular assessment and outcomes after transcatheter tricuspid valve repair

European Heart Journal - Valvular and Structural Heart Disease

4 August 2026
Organised by: Logo
ESC Journals IMAGING Echocardiography Interventional Cardiology VALVULAR, MYOCARDIAL, PERICARDIAL, PULMONARY, CONGENITAL HEART DISEASE Valvular Heart Disease

Abstract

AbstractBackground

Tricuspid regurgitation (TR) and right ventricular (RV) remodelling are closely related. Recent European Society of Cardiology/European Association for Cardio-Thoracic Surgery guidelines on valvular heart disease propose adjusted reference values for RV size and function.

Aims

To determine the predictive value of the proposed RV dilatation and dysfunction thresholds in a real-world interventional cohort.

Methods and Results

Echocardiographic thresholds were evaluated retrospectively in 651 patients, who underwent transcatheter tricuspid valve repair (TTVr) at two tertiary centres.

The primary endpoint was 2-year survival [Kaplan–Meier estimate: 78.6% (74.9–81.9)]. RV strain was the most frequent marker of dysfunction at baseline [free walls strain (FWS) <23% in 80.3%, global longitudinal strain (GLS) <21% in 88.4%]. Proposed cut-offs for RV basal (>24 mm/m2), mid (>21 mm/m2), and tricuspid annular (TA) diameters (>21 mm/m2) were associated with survival (P = .04, <.01, and <.01). Tricuspid annular plane systolic excursion <17 mm was not (P = .24), whereas tissue doppler imaging s′ <10 cm/s and FAC ≤35% were associated with survival (P = .04; .01). Severe RV dysfunction (FWS <11% or GLS <9%) was associated with survival (P < .01; .02). In multivariable analysis, TA >21 mm/m2 [hazard ratio (HR) 2.85 (1.41–5.76); P < .01] and FWS <11% [HR 1.91 (1.07–3.38); P = .03] independently predicted survival. Mortality risk increased for each additional pathological parameter [HR per parameter 1.33 (1.14–1.57); P < .01]. After effective TR reduction (residual TR ≤I; n = 341, 52%), no RV cut-off remained associated with survival.

Conclusions

TTVr is often performed at an advanced disease stage, and adverse RV remodelling is strongly associated with survival. Nevertheless, effective TR reduction attenuated this prognostic value.

Contributors

Jennifer von Stein
Jennifer von Stein

Author

Heart Center at the University of Cologne Cologne , Germany

Philipp von Stein
Philipp von Stein

Author

Cologne University Hospital - Heart Center Cologne , Germany

Felix Rudolph
Felix Rudolph

Author

Heart and Diabetes Center NRW Bad Oeynhausen , Germany

Mohammad Kassar
Mohammad Kassar

Author

University Hospital Basel Basel , Switzerland

Volker Rudolph
Volker Rudolph

Author

Heart and Diabetes Center NRW Bad Oeynhausen , Germany

Christos Iliadis
Christos Iliadis

Author

Cologne University Hospital - Heart Center Cologne , Germany

Roman Pfister
Roman Pfister

Author

Cologne University Hospital - Heart Center Cologne , Germany

Dennis Mehrkens
Dennis Mehrkens

Author

Cologne University Hospital - Heart Center Cologne , Germany